Granules Pharma successfully completes USFDA inspection with zero observations Ruchika Sharma4 Aug 2023 11:45 AM ISTHyderabad: Granules India Limited, announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company, located in...
Granules India arm bags USFDA nod for Acetaminophen and Ibuprofen Tablets Ruchika Sharma14 July 2023 11:09 AM ISTAcetaminophen and Ibuprofen Tablets are used for temporary relief for minor aches and pains due to: headache, toothache, backache, menstrual cramps,...
Granules India completes USFDA audit at Visakhapatnam facility with zero 483 observations Ruchika Sharma3 July 2023 12:30 PM ISTHyderabad: Granules India Limited, a vertically integrated pharmaceutical company, has completed the U.S. Food and Drug Administration’s (US FDA)...
Granules India warns of significant loss of revenue, profitability due to cyber attack Ruchika Sharma29 Jun 2023 3:38 PM ISTThe company said on June 29 that a ransomware group had claimed responsibility for the incident.
USFDA successfully concludes inspection at Granules India Jeedimetla facility Ruchika Sharma24 Jun 2023 12:30 PM ISTHyderabad: Granules India has recently announced that Company’s Jeedimetla facility located at Hyderabad, Telangana, India has successfully completed...
USFDA nod to Granules India Seizure drug Levetiracetam Ruchika Sharma14 Jun 2023 11:43 AM ISTHyderabad: Granules India Limited today announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug...
Granules India bags USFDA nod for Hypertension drug Metoprolol Succinate ER Ruchika Sharma13 Jun 2023 12:48 PM ISTMetoprolol Succinate ER Tablets are indicated for the treatment of hypertension in order to lower blood pressure.
Granules India bags USFDA nod for Venlafaxine Hydrochloride ER Capsules Ruchika Sharma19 May 2023 11:30 AM ISTVenlafaxine HCl extended-release capsules are indicated for the treatment of Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety...
Granules India reports 7.8 percent rise in Q4 profit Ruchika Sharma18 May 2023 4:30 PM ISTBengaluru: Granules India reported a 7.8 per cent rise in fourth-quarter profit, spurred by strong growth in its business of making active...
USFDA nod to Granules India postherpetic neuralgia drug Gabapentin Ruchika Sharma29 March 2023 11:46 AM ISTThe medicine is also indicated as adjunctive therapy in the treatment of partial-onset seizures, with and without secondary generalization, in adults...
Granules India's step-down subsidiary completes USFDA audit with zero observations Ruchika Sharma21 March 2023 2:55 PM ISTHyderabad: Granules India has announced that Granules Consumer Health Inc., a stepdown subsidiary of the Company and a wholly owned subsidiary of...
Granules India bags USFDA okay for hypertension drug Losartan Potassium Ruchika Sharma27 Feb 2023 11:34 AM ISTLosartan potassium tablets are indicated for the treatment of hypertension in adults and pediatric patients 6 years of age and older, to lower blood...
